FDA Inspection
Aurobindo Pharma LimitedAurobindo Pharma Limited – FDA Inspection, Mar 16, 2018
Record Details
This FDA Inspection record concerns Aurobindo Pharma Limited, with an inspection on March 16, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d4cc3587-20be-4443-8712-6e49c304278b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1046218
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.194(a)(4)Complete Test Data
- 21 CFR 211.113(b)Procedures for sterile drug products
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Aurobindo Pharma Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 5, 2025 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2020 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| August 16, 2013 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| June 26, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aurobindo Pharma Limited
- FDA Inspection 1286862 - 2025-09-05
- FDA Inspection 1241780 - 2023-03-09
- FDA Inspection 1118385 - 2020-02-21
- FDA Inspection 847151 - 2013-08-16
- FDA Inspection 793023 - 2012-06-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.